Summary
Global
Markets Direct's, 'Daewoong Pharmaceutical Co., Ltd. - Product Pipeline Review
- 2016', provides an overview of the Daewoong Pharmaceutical Co., Ltd.'s
pharmaceutical research and development focus.
The
report provides comprehensive information on the therapeutics under development
by Daewoong Pharmaceutical Co., Ltd., complete with analysis by stage of
development, drug target, mechanism of action (MoA), route of administration
(RoA) and molecule type. The report also covers the descriptive pharmacological
action of the therapeutics, its complete research and development history and
the dormant and discontinued projects.
Global
Markets Direct's report features investigational drugs from across globe
covering over 20 therapy areas and nearly 3,000 indications. The report is
built using data and information sourced from Global Markets Direct's
proprietary databases, company/university websites, clinical trial registries,
conferences, SEC filings, investor presentations and featured press releases from
company/university sites and industry-specific third party sources. Drug
profiles featured in the report undergoes periodic review following a stringent
set of processes to ensure that all the profiles are updated with the latest
set of information. Additionally, various dynamic tracking processes ensure
that the most recent developments are captured on a real time basis.
Buy a Sample
copy of This Report @ http://www.radiantinsights.com/research/daewoong-pharmaceutical-co-ltd-product-pipeline-review-2016/request-sample
No comments:
Post a Comment